Treatment with GW4869 effectively alleviated the inflammatory response, whereas the instillation of additional sEVs further exacerbated nasal inflammation, with IL‐5 and ECP levels rising by 1.8‐fold and 1.4‐fold compared to the HDM group, respectively. The gene discussed is RNASE3; the disease is inflammatory response.